Sort
25,944 grants matching “neurodegeneration”
Characterization of Orexin/Hypocretin Kinetics in Alzheimer's Disease
$236,250Brendan Patrick Lucey · Washington University · R21 · FY2021 · AG
Nitrogen metabolism in sleep homeostasis and pathology
$236,153Joseph L Bedont · Kent State University · R00 · FY2024 · NS
Impact of actin binding protein Coronin 1C in the pathogenesis of Parkinson's disease
$236,100Birgitt Schuele · Stanford University · R21 · FY2022 · NS
Small Molecule p75 Neurotrophin Receptor Ligand to Treat Huntington's Disease
$236,006Frank M Longo · Stanford University · R21 · FY2013 · NS
Optic Nerve Aging and Glaucoma
$235,937Thasarat Vajaranant · University Of Illinois At Chicago · K23 · FY2017 · EY
Project 4: Amyloid and Tau Mediated Alterations in Memory Function and Cognitive Decline
$235,890Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2016 · AG
Estrogen-neuroprotection due to astroglial Glu transporters occurs via TGF-a/b1
$235,875Eun Sook Yu Lee · Meharry Medical College · SC1 · FY2014 · GM
A novel drug loading method to protect neural cells from oxidative stress induced by a hypoxic/ischemic inflammatory environment
$235,769Kyle J. Lampe · University Of Virginia · R21 · FY2021 · EB
Genetic Study of a Novel Gene Involved in Neurotransmitter Transport
$235,744Stephen Fox Heinemann · Salk Institute For Biological Studies · R21 · FY2011 · MH
Family History of Alzheimer's, Hypometabolism and Oxidative Stress
$235,736Lisa Mosconi · New York University School Of Medicine · R21 · FY2008 · AG
SUMO conjugation in cell biology and Development
$235,735Albert J Courey · University Of California Los Angeles · R01 · FY2010 · GM
Transcriptomic Approaches to TDP-43 Pathology
$235,536Corey T McMillan · University Of Pennsylvania · P01 · FY2022 · AG
Transcriptomic Approaches to TDP-43 Pathology
$235,536Corey T McMillan · University Of Pennsylvania · P01 · FY2024 · AG
Transcriptomic Approaches to TDP-43 Pathology
$235,536Corey T McMillan · University Of Pennsylvania · P01 · FY2023 · AG
Kinase Inhibitors against Neurodegeneration
$235,528Thuris Corporation · R41 · FY2004 · NS
SB Transposons for Gene Therapy
$235,522Chester B Whitley · University Of Minnesota · P01 · FY2011 · HD
Mechanisms of natural phosphatidylserine exposure in the nervous system
$235,520Chun Han · Cornell University · R21 · FY2022 · NS
ATM (Ataxia Telangiectasia Mutated) signaling through cyclin D1
$235,500Masahiro Hitomi · Cleveland Clinic Lerner Com-Cwru · R21 · FY2010 · NS
Tangle Formation in P301L Transgenic Mice
$235,500Mayo Clinic Jacksonville · R01 · FY2005 · AG
P75NTR Small Molecule Ligands for Down Syndrome Therapy
$235,500Frank M Longo · Stanford University · R21 · FY2012 · NS
Development and characterization of an inducible model for myocilin POAG
$235,500Gulab Zode · University Of California-Irvine · R21 · FY2023 · EY
Tangle Formation in P301L Transgenic Mice
$235,500Mayo Clinic Coll Of Med, Jacksonville · R01 · FY2003 · AG
Exploring the mitochondrial function of TSEN in neuronal development and maintenance
$235,500Bingwei Lu · Stanford University · R21 · FY2016 · MH
Assay Development and Discovery of LRRK2 Inhibitors for Parkinson Disease
$235,500Shu G Chen · Case Western Reserve University · R21 · FY2010 · NS
Adenosine A2A receptor cross-activation of TrkB in Huntington's disease
$235,500Donald C Lo · Duke University · R21 · FY2011 · NS